Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and
common cause of non-traumatic neurological disability in young adults. The likelihood for an …

Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature
of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. While their …

Association studies have greatly refined the understanding of how variation within the
human leukocyte antigen (HLA) genes influences risk of multiple sclerosis. However, the …

Multiple sclerosis (MS) is an autoimmune disease that represents a primary cause of
neurological disability in the young adult population. Converging evidence supports the …

Background: Growing evidence suggests an association between adolescent obesity and
increased risk of multiple sclerosis (MS). Objective: The objective of this paper is to …

Aim Multiple sclerosis (MS) is a common and heterogeneous CNS inflammatory
demyelinating disease. The HLA‐DRB1 locus may influence clinical outcome. MS cortical …

Objective: The aim of the present study was to assess the association between HLA-DRB1
and-DQB1 allele groups with the genetic predisposition to multiple sclerosis (MS) in the …

Objective Multiple sclerosis (MS) is one of the leading neurodegenerative causes of physical
disability world-wide. Genetic aberrations of autoimmunity pathway components have been …

One of the most consistent findings in multiple sclerosis (MS) is that development of MS is
linked with carriage of the class II human leucocyte antigen (HLA) molecule HLA-DRB1* 15 …

Multiple sclerosis “MS” is a frequent demyelinating disease that affecting the central nervous
system and associated with a progressive clinical course or severe disability in young …